Last reviewed · How we verify

Escitalopram treatment

National University Hospital, Singapore · FDA-approved active Small molecule Quality 2/100

Escitalopram treatment is a Small molecule drug developed by National University Hospital, Singapore. It is currently FDA-approved. Also known as: Lexapro.

At a glance

Generic nameEscitalopram treatment
Also known asLexapro
SponsorNational University Hospital, Singapore
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Escitalopram treatment

What is Escitalopram treatment?

Escitalopram treatment is a Small molecule drug developed by National University Hospital, Singapore.

Who makes Escitalopram treatment?

Escitalopram treatment is developed and marketed by National University Hospital, Singapore (see full National University Hospital, Singapore pipeline at /company/national-university-hospital-singapore).

Is Escitalopram treatment also known as anything else?

Escitalopram treatment is also known as Lexapro.

What development phase is Escitalopram treatment in?

Escitalopram treatment is FDA-approved (marketed).

Related